March 22, 2012 Vivian Liu President and Chief Executive Officer Innovus Pharmaceuticals, Inc.Innovus Pharmaceuticals, Inc. • March 30th, 2012 • Blank checks
This letter amends the letter agreement between Innovus Pharmaceuticals, Inc. (together with its affiliates and subsidiaries, the “Company”) and Dawson James Securities, Inc. (“Dawson James”) dated December 16, 2011 (the “Engagement Letter”) as follows:
December 16, 2011 Vivian Liu President and Chief Executive Officer Innovus Pharmaceuticals, Inc.Innovus Pharmaceuticals, Inc. • March 30th, 2012 • Blank checks • Florida
This letter confirms our agreement that Innovus Pharmaceuticals, Inc. (together with its affiliates and subsidiaries, the “Company”) has engaged Dawson James Securities, Inc. (“Dawson James” or the “Placement Agent”) to act as the Company’s exclusive Placement Agent on a commercially reasonable best efforts basis in connection with the proposed private placement (the “Offering”) of equity or equity-linked securities (the “Securities”) of the Company. The private placement Securities will consist of units that include shares of common stock and warrants to purchase shares of common stock (the “Units”). The gross proceeds of the Offering will be a minimum of five million dollars ($5,000,000) and a maximum of ten million dollars ($10,000,000) with a two million ($2,000,000) overallotment option to increase the Offering to a maximum of twelve million dollars ($12,000,000) at the discretion of the Placement Agent
